AUPH

Aurinia Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality7/10
  • Growth↑ 9/10
  • Value↓ 3/10
Aurinia Pharmaceuticals sales and earnings growth
AUPH Growth
Great
  • Revenue Y/Y↑ 24.59%
  • EPS Y/Y↑ 668.97%
  • FCF Y/Y↑ 160.38%
Aurinia Pharmaceuticals gross and profit margin trends
AUPH Profitability
Great
  • Gross margin ↑ 89.70%
  • EPS margin↑ 100.00%
  • ROIC 5Y↑ 1.57%
Aurinia Pharmaceuticals net debt vs free cash flow
AUPH Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.2
  • Interest coverage↑ 32.3

Aurinia Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks